Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Extracellular superoxide dismutase (EC-SOD) is an antioxidant enzyme that catalyzes the dismutation of superoxide radicals into hydrogen peroxide and oxygen in the extracellular space. It is encoded by the SOD3 gene in humans and forms a glycosylated homotetramer that contains copper and zinc ions in its active site. EC-SOD has a unique heparin-binding domain that allows it to bind to the extracellular matrix and cell surfaces through interactions with heparan sulfate proteoglycan and collagen. This enzyme plays a critical role in protecting tissues from oxidative stress, particularly in the brain, lungs, and cardiovascular system.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on extracellular superoxide dismutase.